Lataa...
Four‐factor prothrombin complex concentrate reverses apixaban‐associated bleeding in a rabbit model of acute hemorrhage
BACKGROUND: Apixaban is a direct factor Xa inhibitor approved for the treatment and prevention of thromboembolic disease. There is a lack of data regarding its reversal in cases of acute bleeding or prior to emergency surgery that needs addressing. OBJECTIVES: This study assessed whether a four‐fact...
Tallennettuna:
| Julkaisussa: | J Thromb Haemost |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4738416/ https://ncbi.nlm.nih.gov/pubmed/26447393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.13165 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|